Drug Shortage Report for EPHEDRINE SULFATE INJECTION USP
Report ID | 157408 |
Drug Identification Number | 00876534 |
Brand name | EPHEDRINE SULFATE INJECTION USP |
Common or Proper name | EPHEDRINE SO4 |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | EPHEDRINE SULFATE |
Strength(s) | 50MG |
Dosage form(s) | LIQUID |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1ML 10LIAM |
ATC code | C01CA |
ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-03-25 |
Estimated end date | 2022-04-01 |
Actual end date | 2022-03-30 |
Shortage status | Resolved |
Updated date | 2022-03-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-03-31 | English | Compare |
v5 | 2022-03-30 | French | Compare |
v4 | 2022-03-30 | English | Compare |
v3 | 2022-03-26 | English | Compare |
v2 | 2022-03-25 | French | Compare |
v1 | 2022-03-25 | English | Compare |
Showing 1 to 6 of 6